# Treatment Response in Dialysis Anaemia

> **NCT02707757** · PHASE4 · COMPLETED · sponsor: **Imperial College Healthcare NHS Trust** · enrollment: 197 (actual)

## Conditions studied

- Anaemia
- Haemodialysis

## Interventions

- **DRUG:** Iron sucrose
- **DRUG:** Erythopoietin stimulating agent

## Key facts

- **NCT ID:** NCT02707757
- **Lead sponsor:** Imperial College Healthcare NHS Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-07
- **Primary completion:** 2016-12
- **Final completion:** 2017-04
- **Target enrollment:** 197 (ACTUAL)
- **Last updated:** 2021-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02707757

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02707757, "Treatment Response in Dialysis Anaemia". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02707757. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*